Corporation
Lifestyle
Cellid Crashes in After-Hours Trading Following Phase 3 Failure...Shaperon Plummets 25% [K-bio pulse]
In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine clinical trial results, but the shares plunged by the daily limit in after-hours trading following news…
Lifestyle
Cellid Co., Ltd. Hits After-Hours Lower Circuit Breaker Following Phase 3 ‘Failure’… Shaperon Inc. Also Drops 25% [Bio Spotlight]
On the 26th, shares of Cellid Co., Ltd.(299660) surged significantly in the pharmaceutical and biotech sector amid expectations for the announcement of clinical trial results for a vaccine currently i…
Lifestyle
GENINUS Inc. Receives Interest from Big Pharma at ‘Bio USA’… Expectations Rise for ‘Intellibil’ Technology Export
Geninus ( GENINUS Inc.(389030)) announced on the 30th that it had successfully concluded discussions on technology transfer and business development with global pharmaceutical companies at the “Bio In…
Lifestyle
Shin Dong-ju’s Return to Lotte Holdings Falls Through Again… 12th Failure
Shin Dong-ju (pictured), the eldest son of the late Shin Kyuk-ho, founder of Lotte Group, and former vice chairman of Lotte Holdings (currently chairman of SDJ Corporation), has once again failed in h…
Lifestyle
SEERS and Mobicare Receive U.S. FDA 510(k) Clearance… "Full-Scale Entry into the Medicare Market Begins"
SEERS TECHNOLOGY(458870), a wearable artificial intelligence (AI) diagnostic and monitoring company, announced on the 29th that its wearable electrocardiogram (ECG) device, “mobiCARE,” has received 51…
Lifestyle
'U.S. Government Streamlines Clinical Trial Plans and Phase 1 Procedures'... Celltrion Gains Momentum for 20 New Drugs
Celltrion(068270)is expected to further accelerate its global new drug development efforts, buoyed by the U.S. health authorities’ sudden policy shift toward clinical development innovation. At a time…
Lifestyle
Embolization Techniques: Shift from Permanent to Temporary Occlusion... NextBio’s Value Set to Rise
The paradigm in the embolization (a procedure that treats lesions by blocking blood vessels) market is shifting. The medical community appears to be shifting away from the traditional approach of perm…
Lifestyle
Biotechnology Act Revises NK Cell Therapy Classification to ‘Low Risk’… Vaxcell-Bio Therapeutics Expected to Benefit Most
With the establishment of an institutional framework that will enable advanced regenerative medicine treatments using autologous natural killer (NK) cells to be carried out more swiftly in South Korea…
Lifestyle
LF Ate Sells 310,000 Lip Balms via Kakao's "Gift" Feature
Ate, the beauty brand of lifestyle and culture company LF(093050), continues to enjoy success with its lip balms on KakaoTalk’s “Gift” service. To capitalize on this demand, the brand has unveiled a n…
Lifestyle
OTOKI Holds Awards Ceremony for Illustration Contest
Ottogi(007310)announced on the 29th that it held the awards ceremony for the 4th OTOKI Illustration Contest on the 26th at Ham Tae-ho Hall in Gangnam-gu, Seoul.
This year’s contest was themed a…